ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Bladder Cancer RFA From Organ Systems Program

June 6, 1986

Excerpts From Potti’s Application to Practice Medicine In South Carolina

December 9, 2011

ECOG Phase III Trial To Test Hormones Vs. Chemotherapy For Prostate Cancer.

July 4, 2003

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

July 25, 2014

President’s Cancer Panel annual report finds barriers in translational research stall progress.

July 8, 2005

Clinical Research: Enough Studies Done, Time For Solutions, CSR Report Says

February 20, 1998